Literature DB >> 9218727

Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells.

M Ligueros1, D Jeoung, B Tang, D Hochhauser, M M Reidenberg, M Sonenberg.   

Abstract

The antiproliferative effects of gossypol on human MCF-7 mammary cancer cells and cyclin D1-transfected HT-1060 human fibrosarcoma cells were investigated by cell cycle analysis and effects on the cell cycle regulatory proteins Rb and cyclin D1. Flow cytometry of MCF-7 cells at 24 h indicated that 10 microM gossypol inhibited DNA synthesis by producing a G1/S block. Western blot analysis using anti-human Rb antibodies and anti-human cyclin D1 antibodies in MCF-7 cells and high- and low-expression cyclin D1-transfected fibrosarcoma cells indicated that, after 6 h exposure, gossypol decreased the expression levels of these proteins in a dose-dependent manner. Gossypol also decreased the ratio of phosphorylated to unphosphorylated Rb protein in human mammary cancer and fibrosarcoma cell lines. Gossypol (10 microM) treated also decreased cyclin D1-associated kinase activity on histone H1 used as a substrate in MCF-7 cells. These results suggest that gossypol might suppress growth by modulating the expression of cell cycle regulatory proteins Rb and cyclin D1 and the phosphorylation of Rb protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218727      PMCID: PMC2223792          DOI: 10.1038/bjc.1997.330

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

Review 1.  Analytical luminescence: its potential in the clinical laboratory.

Authors:  T P Whitehead; L J Kricka; T J Carter; G H Thorpe
Journal:  Clin Chem       Date:  1979-09       Impact factor: 8.327

2.  Cytocidal effect of gossypol on cultured murine erythroleukemia cells is prevented by serum protein.

Authors:  H C Haspel; Y F Ren; K A Watanabe; M Sonenberg; R E Corin
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

3.  Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro.

Authors:  Y Wang; P N Rao
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

4.  The effect of the association of Gossypol and Lonidamine on the energy metabolism of Ehrlich ascites tumor cells.

Authors:  A Floridi; S D'Atri; R Menichini; M L Marcante; A Nista; B Silvestrini; A Caputo; C De Martino
Journal:  Exp Mol Pathol       Date:  1983-06       Impact factor: 3.362

5.  Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines.

Authors:  G P Tuszynski; G Cossu
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

6.  Antitumor effects of gossypol on murine tumors.

Authors:  P N Rao; Y C Wang; E Lotzova; A A Khan; S P Rao; L C Stephens
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.

Authors:  D Hochhauser; B Schnieders; E Ercikan-Abali; R Gorlick; R Muise-Helmericks; W W Li; J Fan; D Banerjee; J R Bertino
Journal:  J Natl Cancer Inst       Date:  1996-09-18       Impact factor: 13.506

8.  Effect of gossypol on erythrocyte membrane function: specific inhibition of inorganic anion exchange and interaction with band 3.

Authors:  H C Haspel; R E Corin; M Sonenberg
Journal:  J Pharmacol Exp Ther       Date:  1985-09       Impact factor: 4.030

9.  Inhibition of DNA polymerase alpha by gossypol.

Authors:  L J Rosenberg; R C Adlakha; D M Desai; P N Rao
Journal:  Biochim Biophys Acta       Date:  1986-05-05

10.  Cytotoxicity of enantiomers of gossypol.

Authors:  A E Joseph; S A Matlin; P Knox
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more
  20 in total

1.  The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells.

Authors:  Ping Gao; Chantal Bauvy; Sylvie Souquère; Giovanni Tonelli; Lei Liu; Yushan Zhu; Zhenzhen Qiao; Daniela Bakula; Tassula Proikas-Cezanne; Gérard Pierron; Patrice Codogno; Quan Chen; Maryam Mehrpour
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  Anti-inflammatory Effects of Gossypol on Human Lymphocytic Jurkat Cells via Regulation of MAPK Signaling and Cell Cycle.

Authors:  Chien-Wei Chen; Sindy Hu; Ke-Hung Tsui; Guey-Shyang Hwang; Szu-Tah Chen; Tswen-Kei Tang; Hao-Tsai Cheng; Ju-Wen Yu; Hsiao-Chiu Wang; Horng-Heng Juang; Paulus S Wang; Shyi-Wu Wang
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

3.  Gossypol treatment of recurrent adult malignant gliomas.

Authors:  P Bushunow; M M Reidenberg; J Wasenko; J Winfield; B Lorenzo; S Lemke; B Himpler; R Corona; T Coyle
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 4.  Bcl-2 antagonists: a proof of concept for CLL therapy.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Invest New Drugs       Date:  2013-08-02       Impact factor: 3.850

5.  The Lactate Dehydrogenase Inhibitor Gossypol Inhibits Radiation-Induced Pulmonary Fibrosis.

Authors:  Jennifer L Judge; Shannon H Lacy; Wei-Yao Ku; Kristina M Owens; Eric Hernady; Thomas H Thatcher; Jacqueline P Williams; Richard P Phipps; Patricia J Sime; R Matthew Kottmann
Journal:  Radiat Res       Date:  2017-05-02       Impact factor: 2.841

6.  Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Kumudha Balakrishnan; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

7.  Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.

Authors:  Xian-Qing Zhang; Xiao-Feng Huang; Shi-Jie Mu; Qun-Xing An; Ai-Jun Xia; Rui Chen; Dao-Cheng Wu
Journal:  Asian J Androl       Date:  2010-01-18       Impact factor: 3.285

Review 8.  Cyclin D1 and human neoplasia.

Authors:  R Donnellan; R Chetty
Journal:  Mol Pathol       Date:  1998-02

9.  Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors.

Authors:  Guo-Yan Liu; Qi Luo; Bin Xiong; Chao Pan; Ping Yin; Hong-Feng Liao; Wei-Chun Zhuang; Hong-Zhi Gao
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

10.  Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.

Authors:  Robert Matthew Kottmann; Emma Trawick; Jennifer L Judge; Lindsay A Wahl; Amali P Epa; Kristina M Owens; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.